Skip to main content
David Hong

Dr David Hong
Ph.D, MRSC

Contact

Davidhwq@liverpool.ac.uk

+44 (0)151 795 1299 Ext. 51299

Research

Research grants

Optimisation of the Antimalarial and DMPK Properties of A Series of Plasmepsin IX/X Beta-hydroxyethylamine Based Inhibitors

LIVERPOOL SCHOOL OF TROPICAL MEDICINE (UK)

March 2021 - August 2022

The role of chemosensory proteins in pyrethroid resistance

BIOTECHNOLOGY & BIOLOGICAL SCIENCE RESEARCH COUNCIL

April 2021 - March 2024

Chemical synthesis enabling hit confirmation of screening a macrocycle library against resistant bacteria

ROYAL SOCIETY OF CHEMISTRY (UK)

September 2021 - August 2022

Phase II Clinical Development of AWZ1066S, a Small Molecule anti-Wolbachia Candidate Macrofilaricide Drug

GLOBAL HEALTH INNOVATIVE TECHNOLOGY FUND - GHIT (JAPAN)

October 2022 - September 2024

Lead Optimisation of a Series of Antimalarial Plasmepsin IX/X Betahydroxyethylamine Based Inhibitors

MEDICAL RESEARCH COUNCIL

February 2024 - October 2026

An anti-Wolbachia azaquinazoline small molecule as a preventative drug candidate for veterinary heartworm disease

ROYAL VETERINARY COLLEGE(UK)

November 2021 - September 2022

National Hub for Advanced Long-acting Therapeutics (HALo)

ENGINEERING & PHYSICAL SCIENCES RESEARCH COUNCIL

November 2024 - October 2030

Anti-Wolbachia targeted macrofilaricidal drug discovery - lead optimization to deliver novel pre-clinical candidates with utility in Onchocerciasis and Lymphatic filariasis

LIFEARC (UK)

November 2024 - March 2026